Nothing
iDOVE: Durability of Vaccine Efficacy Against SARS-CoV-2 Infection
Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) <doi:10.1093/cid/ciab630>.
Package details |
|
|---|---|
| Author | Yu Gu [aut], Shannon T. Holloway [aut, cre], Dan-Yu Lin [aut] |
| Maintainer | Shannon T. Holloway <shannon.t.holloway@gmail.com> |
| License | GPL-2 |
| Version | 1.5 |
| Package repository | View on CRAN |
| Installation |
Install the latest version of this package by entering the following in R:
|
Try the iDOVE package in your browser
Any scripts or data that you put into this service are public.
